For Amesite Inc. Our host for today's call is Dr. Anne Marie Sastry, President, Chief Executive Officer, and Chairman. I will now turn the call over to your host, Dr. Anne Marie Sastry. You may begin. Thank you very much. Good morning, and welcome to the 2025 Annual Stockholders' Meeting of Amesite Inc. I'm Dr. Anne Marie Sastry, President, Chief Executive Officer, and Chairman of the Board of Directors of Amesite Inc. It's my pleasure to welcome you here today for this meeting, and I hope everyone is keeping warm. We're excited to be hosting our virtual meeting, which allows us to be more inclusive and reach a greater number of our stockholders. We have stockholders attending via the web portal, and as is our custom, we will conduct the business portion of our meeting first and answer questions at the end of the meeting. Though we may not be able to answer every question, we will do our best to provide a response to as many as possible. In keeping with the digital approach to this year's meeting, it is now 8:45 A.M. Eastern Time on January 21st, 2025, and this meeting is officially called to order. And now I would like to introduce the other member of the board present today. J. Michael Losh has served as one of our directors since February 2018. Now, it's my pleasure to introduce Sean Reid of Sheppard Mullin Richter & Hampton LLP, the company's outside counsel. He will act as Secretary of the meeting. I will turn to him with any procedural issues that may arise. Sean? Thank you, Anne Marie. We are also joined here today by the company's independent auditors. They will be available during the question-and-answer session after the meeting to respond to appropriate questions. And finally, the company has appointed Sarah Berman, Principal Financial and Accounting Officer for the company, to act as Inspector of Elections. Ms. Berman is with us today and has taken the oath of Inspector of Election. Thank you, Sean. After the formal meeting has been adjourned, we will provide time for general questions. Only validated stockholders may ask questions in the designated field on the web portal. Out of consideration for others, please limit yourself to one question. Please note that this meeting is being recorded. However, no one attending via the webcast or telephone is permitted to use any audio recording device. The Board of Directors fixed November 26, 2024, as the record date for determining stockholders entitled to vote at this meeting. An affidavit has been delivered attesting to the fact that either, one, a notice of internet availability of the notice of the meeting, the proxy statement, and the 2024 annual report to the stockholders, or two, the documents themselves were mailed on or about November 27, 2024, to all stockholders as of the record date and will be incorporated into the minutes of this meeting. The stockholder list shows that, as of the record date, there were 2,792,440 shares of common stock outstanding and entitled to vote at the meeting. We are informed by the Inspector of Elections that there are represented in person or by proxy shares of common stock representing 1,324,759 votes, or approximately 44% of the voting power on the record date. Since this represents more than one-third of the voting power of all issued and outstanding stock entitled to vote on the record date, a quorum is present for the purposes of transacting business. Now for the proposals. Sean? Thanks, Anne Marie. Now I will present the matters to be voted upon. Please note that we will give stockholders an opportunity to comment on the proposals themselves after all proposals have been presented. Proposal one is the election of one Class I Director to hold office for a full term of three years or until his successor is duly elected and qualified. Proposal two is the ratification of the appointment of Turner, Stone & Company, L.L.P. as the company's independent registered public accounting firm for the fiscal year ending June 30, 2025. If any stockholder would like to make a comment regarding any of the proposals, please submit your comment through the web portal. Thank you, Sean. It is now 8:49 A.M. Eastern Time on January 21st, 2025, and the polls are now open. Any stockholder who hasn't yet voted or wishes to change their vote may do so by clicking on the voting button on the web portal and following the instructions there. Stockholders who have sent in proxies or voted via telephone or internet and do not want to change their vote do not need to take any further action. We are pausing for voting, and if you're joining now, we are paused for voting. We're pausing another 10 seconds for voting. Now that everyone has had the opportunity to vote, I now declare the polls for the 2025 Annual Stockholder Meeting closed. Sean? Thank you, Anne Marie. We have been informed by the Inspector of Elections that the preliminary vote report shows that the nominee for election to the board has been duly elected and the ratification of our independent registered public accounting firm has been approved. We will be reporting the final vote results in a Form 8-K to be filed at the SEC within four business days. With that, I turn the meeting back over to Anne Marie. Thanks very much, Sean. There being no further business to come before the meeting, the annual meeting of the stockholders of Amesite Inc. is now adjourned. Now I will give a brief presentation of Amesite's business, followed by our question-and-answer session. As those of you who have been following us know, this year marks several successes in our new product, Nurse Magic. Nurse Magic was launched last year and quickly gained traction. We have users in all 50 states and over 21 countries and 87 different professions. We're thrilled with the user response of this tool and are now selling into health and home care agencies in addition to the B2C sale. We're very optimistic about this product because instead of a training tool, this product changes the stop, train, test, and do cycle into just do. This product enables nurses and other healthcare professionals to get information, write their documentation with ease, and answer questions all in a single app. We're thrilled with the outcome of this, and we're excited for what 2025 will bring. Now we will take questions entered on the web portal. Please note we will attempt to answer as many questions as time allows, but only questions that are germane to the meeting will be addressed. Any appropriate questions that we do not answer during the meeting will be addressed on our company website. So going over to questions. The first question, the new product Nurse Magic seems to write documentation for healthcare. Why is Amesite limiting this to nurses? Very good question. As I stated earlier, we have over 87 different professions from anesthesiologists to EMTs to nurses who've registered to use the app. Nurses actually represent the largest segment of healthcare workers at approximately 5.2 million in the United States alone. We targeted nurses for reasons of fatigue, burnout, and challenge with completing documentation during shifts. This is well known. 40% of nurses' time is spent on documentation. That, coupled with the fact that I've mentioned earlier that nurses are the largest segment, were the reasons that we targeted nurses, and we've been delighted to have so many RNs sign up to use the product. There's another question. There was high insider participation on the last financing. Give some details on this. I'm happy to do so. As those of you who've been following us know, we did complete a confidentially marketed public offering in January that brought $3.6 million to the company to continue to execute on plan. I participated with $1 million in that round, and George Parmer and Gil Omenn also participated for another $260,000. So insider participation was high. Of course, we're thrilled with this. We think that this is a strong show of support for the company and our business plan, and we're excited to see again what 2025 brings. That concludes our meeting. We thank you for your attendance today and continued support. Thank you and have a great day.